Given that mTORC2 is a key driver of cancer cell survival (36, 37), we assessed apoptosis in cells treated with PP242 by measuring the activity of caspase 3/7, a key molecular switch in the intrinsic apoptotic cascade. The gene discussed is CASP3; the disease is cancer.